Principal Financial Group Inc Sarepta Therapeutics, Inc. Transaction History

Principal Financial Group Inc

  • $167 Billion
  • Q1 2025

A detailed history of Principal Financial Group Inc transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 244,766 shares of SRPT stock, worth $14.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
244,766
Previous 282,084 13.23%
Holding current value
$14.9 Million
Previous $34.3 Million 54.46%
% of portfolio
0.01%
Previous 0.02%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 28, 2025
SELL
$63.82 - $127.89 $2.38 Million - $4.77 Million
-37,318 Reduced 13.23%
244,766 $15.6 Million
Q4 2024

Jan 31, 2025
BUY
$104.54 - $137.94 $29.5 Million - $38.9 Million
282,084 New
282,084 $34.3 Million
Q3 2024

Oct 31, 2024
SELL
$124.33 - $156.75 $11.9 Million - $15 Million
-95,974 Reduced 26.44%
267,037 $33.4 Million
Q2 2024

Jul 29, 2024
BUY
$113.33 - $163.85 $36 Million - $52 Million
317,277 Added 693.74%
363,011 $57.4 Million
Q1 2024

Apr 29, 2024
SELL
$93.7 - $141.53 $356,528 - $538,521
-3,805 Reduced 7.68%
45,734 $5.92 Million
Q4 2023

Feb 07, 2024
BUY
$67.31 - $124.76 $1.85 Million - $3.44 Million
27,549 Added 125.28%
49,539 $4.78 Million
Q3 2023

Nov 02, 2023
BUY
$102.5 - $123.59 $81,487 - $98,254
795 Added 3.75%
21,990 $2.67 Million
Q2 2023

Aug 07, 2023
BUY
$106.4 - $157.19 $17,875 - $26,407
168 Added 0.8%
21,195 $2.43 Million
Q1 2023

May 09, 2023
SELL
$117.53 - $155.99 $279,603 - $371,100
-2,379 Reduced 10.16%
21,027 $2.9 Million
Q4 2022

Feb 09, 2023
BUY
$100.86 - $132.13 $352,203 - $461,397
3,492 Added 17.54%
23,406 $3.03 Million
Q3 2022

Nov 09, 2022
SELL
$75.71 - $119.24 $112,126 - $176,594
-1,481 Reduced 6.92%
19,914 $2.2 Million
Q2 2022

Aug 10, 2022
BUY
$62.69 - $88.44 $247,061 - $348,542
3,941 Added 22.58%
21,395 $1.6 Million
Q1 2022

May 09, 2022
SELL
$63.15 - $90.42 $74,011 - $105,972
-1,172 Reduced 6.29%
17,454 $1.36 Million
Q4 2021

Feb 09, 2022
SELL
$77.28 - $99.42 $399,769 - $514,299
-5,173 Reduced 21.74%
18,626 $1.68 Million
Q3 2021

Nov 09, 2021
SELL
$65.97 - $92.48 $196,788 - $275,867
-2,983 Reduced 11.14%
23,799 $2.2 Million
Q2 2021

Aug 10, 2021
SELL
$69.38 - $86.75 $4,370 - $5,465
-63 Reduced 0.23%
26,782 $2.08 Million
Q1 2021

May 10, 2021
BUY
$72.25 - $168.95 $108,953 - $254,776
1,508 Added 5.95%
26,845 $2 Million
Q4 2020

Feb 08, 2021
BUY
$125.56 - $178.74 $26,242 - $37,356
209 Added 0.83%
25,337 $4.32 Million
Q3 2020

Nov 06, 2020
SELL
$127.12 - $172.34 $268,604 - $364,154
-2,113 Reduced 7.76%
25,128 $3.53 Million
Q2 2020

Aug 05, 2020
BUY
$93.0 - $171.7 $725,679 - $1.34 Million
7,803 Added 40.14%
27,241 $4.37 Million
Q1 2020

May 12, 2020
BUY
$82.38 - $131.64 $62,855 - $100,441
763 Added 4.09%
19,438 $1.9 Million
Q4 2019

Feb 05, 2020
SELL
$76.53 - $135.58 $7,806 - $13,829
-102 Reduced 0.54%
18,675 $2.41 Million
Q3 2019

Nov 13, 2019
SELL
$72.81 - $156.91 $202,630 - $436,680
-2,783 Reduced 12.91%
18,777 $1.42 Million
Q2 2019

Aug 12, 2019
BUY
$112.21 - $151.95 $148,117 - $200,573
1,320 Added 6.52%
21,560 $3.28 Million
Q1 2019

May 10, 2019
BUY
$106.67 - $151.68 $313,396 - $445,635
2,938 Added 16.98%
20,240 $2.41 Million
Q4 2018

Feb 14, 2019
SELL
$97.32 - $148.76 $194,931 - $297,966
-2,003 Reduced 10.38%
17,302 $1.89 Million
Q3 2018

Nov 14, 2018
BUY
$115.31 - $161.51 $89,595 - $125,493
777 Added 4.19%
19,305 $3.12 Million
Q2 2018

Aug 13, 2018
SELL
$71.74 - $153.69 $101,727 - $217,932
-1,418 Reduced 7.11%
18,528 $0
Q1 2018

May 14, 2018
BUY
$54.02 - $82.27 $28,630 - $43,603
530 Added 2.73%
19,946 $1.48 Million
Q4 2017

Feb 13, 2018
BUY
$47.64 - $56.75 $502,268 - $598,315
10,543 Added 118.82%
19,416 $1.08 Million
Q3 2017

Nov 02, 2017
BUY
$35.73 - $47.15 $317,032 - $418,361
8,873
8,873 $402,000

Others Institutions Holding SRPT

# of Institutions
521
Shares Held
85.9M
Call Options Held
1.55M
Put Options Held
1.37M
View Full List

About Sarepta Therapeutics, Inc.

SRPT Quotes by TradingView
  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $5.33B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email